Safety Alert for Commercial Name: EP NAVIGATION SYSTEM - CARTO System 3 Technical Name: SURGICAL NAVIGATION SYSTEM ANVISA Registration Number: 80145901192 Hazard Class: III Affected Model: CARTO System 3 Affected serial numbers: SKU FG540000 and FG540000U

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Johnson & Johnson do Brasil Ind. e Com. de Prod. para Saúde Ltda; Biosense Webster, Inc.; Biosense Webster (Israel) Ltd..

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    2237
  • Date
    2017-03-20
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    Some instructions are recommended: 1. Do not ignore system indicators such as significant noise during ablation or an Error 7 message (a leakage current fault available in some configurations of the CARTO® System 3). Follow the Instructions for Use and stop using the system if there is a suspected leak. 2. Do not perform ablation while the impedance readings of the ablation catheter are in extreme values ​​beyond 250 O (or 300 O in the case of the Multichannel RF Generator MARQ®1). Monitor the impedance during the procedure and avoid turning off the Impedance Limit Setting on the radio frequency (RF) generator. [NOTE: If you are performing a procedure with an experimental device in a clinical study, follow the requirements of the approved protocol]. 3. In addition, avoid ablation during pacing with the same electrode of the ablation catheter. 4. Stay aware of this notice and pass it on to everyone at your workplace who needs to be informed and complete, sign, and return the Business Response Form.
  • Reason
    Biosense webster, a division of johnson & johnson medical nv / sa, recently became aware of workflow scenarios that could lead to current leakage. leakage of currents has the potential to induce a ventricular arrhythmia.
  • Action
    Field Action Code 17000004 triggered under the responsibility of Johnson & Johnson do Brasil Ind. And Com. De Prod. for Health Ltda. Company will update, correct or supplement the instructions for use.